WHO ICTRP trial
Effects of remimazolam and propofol on sleep quality in patients undergoing…
ChiCTR2200063114 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200063114 |
|---|---|
| Public title | Effects of remimazolam and propofol on sleep quality in patients undergoing gastrointestinal endoscopy |
| Scientific title | Effects of remimazolam and propofol on sleep quality in patients undergoing gastrointestinal endoscopy |
| Primary sponsor | Qingdao Central Medical Group |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Sleep Disorders |
| Interventions | Remazolam group:The patient will be anesthetized by intravenous injection of remimazolam;Propofol group:The patient will be anesthetized by intravenous injection of propofol |
| Registration date | Aug 31, 2022 |
| Target size | Remazolam group:178;Propofol group:178 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: